全文获取类型
收费全文 | 1966篇 |
免费 | 327篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 47篇 |
妇产科学 | 32篇 |
基础医学 | 335篇 |
口腔科学 | 106篇 |
临床医学 | 151篇 |
内科学 | 612篇 |
皮肤病学 | 23篇 |
神经病学 | 174篇 |
特种医学 | 51篇 |
外科学 | 298篇 |
综合类 | 62篇 |
预防医学 | 174篇 |
眼科学 | 8篇 |
药学 | 94篇 |
肿瘤学 | 122篇 |
出版年
2021年 | 20篇 |
2020年 | 21篇 |
2019年 | 29篇 |
2018年 | 38篇 |
2017年 | 25篇 |
2016年 | 30篇 |
2015年 | 53篇 |
2014年 | 49篇 |
2013年 | 82篇 |
2012年 | 94篇 |
2011年 | 116篇 |
2010年 | 67篇 |
2009年 | 64篇 |
2008年 | 87篇 |
2007年 | 102篇 |
2006年 | 86篇 |
2005年 | 75篇 |
2004年 | 80篇 |
2003年 | 88篇 |
2002年 | 50篇 |
2001年 | 52篇 |
2000年 | 58篇 |
1999年 | 72篇 |
1998年 | 26篇 |
1997年 | 29篇 |
1996年 | 25篇 |
1995年 | 27篇 |
1994年 | 15篇 |
1993年 | 16篇 |
1992年 | 41篇 |
1991年 | 39篇 |
1990年 | 37篇 |
1989年 | 40篇 |
1988年 | 43篇 |
1987年 | 33篇 |
1986年 | 35篇 |
1985年 | 37篇 |
1984年 | 24篇 |
1983年 | 28篇 |
1980年 | 20篇 |
1979年 | 34篇 |
1978年 | 26篇 |
1977年 | 17篇 |
1976年 | 22篇 |
1975年 | 19篇 |
1974年 | 25篇 |
1973年 | 21篇 |
1972年 | 19篇 |
1970年 | 15篇 |
1966年 | 13篇 |
排序方式: 共有2299条查询结果,搜索用时 15 毫秒
51.
52.
Gaudet MM Falk RT Stevens RD Gunter MJ Bain JR Pfeiffer RM Potischman N Lissowska J Peplonska B Brinton LA Garcia-Closas M Newgard CB Sherman ME 《The Journal of clinical endocrinology and metabolism》2012,97(9):3216-3223
Context: Endometrial cancer is associated with metabolic disturbances related to its underlying risk factors, including obesity and diabetes. Identifying metabolite biomarkers associated with endometrial cancer may have value for early detection, risk assessment, and understanding etiology. Objective: The objective of the study was to evaluate the reliable measurement of metabolites in epidemiological studies with nonstandardized blood collection; confirm previously reported correlations of metabolites with body size; and assess differences in metabolite levels between cases and controls. Design: This was the Polish Endometrial Cancer Study (2001-2003). Setting: This study was a population-based case-control study. Patients: Patients included 250 cases and 250 controls. Intervention: The intervention included the measurement of serum metabolite levels of 15 amino acids, 45 acylcarnitines, and nine fatty acids. Main Outcome Measure: The main outcome measure was endometrial cancer. Results: Body mass index was correlated with levels of valine (r = 0.26, P = 3.4 × 10(-5)), octenoylcarnitine (r = 0.24, P = 1.5 × 10(-4)), palmitic acid (r = 0.26, P = 4.4 × 10(-5)), oleic acid (r = 0.28, P = 9.9 × 10(-6)), and stearic acid (r = 0.26, P = 2.9 × 10(-5)) among controls. Only stearic acid was inversely associated with endometrial cancer case status (quartile 4 vs. quartile 1: odds ratio 0.37, 95% confidence interval 0.20-0.69, P for trend = 1.2 × 10(-4)). Levels of the C5-acylcarnitines, octenoylcarnitine, decatrienoylcarnitine, and linoleic acid were significantly lower in cases than controls (odds ratios ranged from 0.21 to 0.38). Conclusions: These data demonstrate that previously reported variations in metabolomic profiles with body mass index can be replicated in population-based studies with nonfasting blood collection protocols. We also provide preliminary evidence that large differences in metabolite levels exist between cases and controls, independent of body habitus. Our findings warrant assessment of metabolic profiles, including the candidate markers identified herein, in prospectively collected blood samples to define biomarkers and etiological factors related to endometrial cancer. 相似文献
53.
54.
55.
56.
J Tang DJ Humes E Gemmil NT Welch SL Parsons JA Catton 《Annals of the Royal College of Surgeons of England》2013,95(5):323-328
Introduction
The high mortality and morbidity associated with resection for oesophagogastric malignancy has resulted in a conservative approach to the postoperative management of this patient group. In August 2009 we introduced an enhanced recovery after surgery (ERAS) pathway tailored to patients undergoing resection for oesophagogastric malignancy. We aimed to assess the impact of this change in practice on standard clinical outcomes.Methods
Two cohorts were studied of patients undergoing resection for oesophagogastric malignancy before (August 2008 – July 2009) and after (August 2009 – July 2010) the implementation of the ERAS pathway. Data were collected on demographics, interventions, length of stay, morbidity and in-hospital mortality.Results
There were 53 and 55 oesophagogastric resections undertaken respectively for malignant disease in each of the study periods. The median length of stay for both gastric and oesophageal resection decreased from 15 to 11 days (Mann– Whitney U, p<0.001) following implementation of the ERAS pathway. There was no significant increase in morbidity (gastric resection 23.1% vs 5.3% and oesophageal resection 25.9% vs 16.7%) or mortality (gastric resection no deaths and oesophageal resection 1.8% vs 3.6%) associated with the changes. There was a significant decrease in the number of oral contrast studies used following oesophageal resection, with a reduction from 21 (77.8%) in 2008–2009 to 6 (16.7%) in 2009–2010 (chi-squared test, p<0.0001).Conclusions
The introduction of an enhanced recovery programme following oesophagogastric surgery resulted in a significant decrease in length of median patient stay in hospital without a significant increase in associated morbidity and mortality. 相似文献57.
58.
59.
60.